| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/02/2000 | EP0975963A1 Prostate specific antigen substrates |
| 02/02/2000 | EP0975810A1 Method of pcr testing of pooled blood samples |
| 02/02/2000 | EP0975790A1 New method for isolating polysaccharides |
| 02/02/2000 | EP0975773A1 Dna sequences, molecules, vectors and vaccines for feline calicivirus disease and methods for producing and using same |
| 02/02/2000 | EP0975772A1 Reagents and methods useful for detecting diseases of the gastrointestinal tract |
| 02/02/2000 | EP0975769A1 Novel prostate-associated kallikrein |
| 02/02/2000 | EP0975759A1 Human tumor-associated kazal inhibitor |
| 02/02/2000 | EP0975757A2 Dictyocaulus viviparus antigen for the diagnosis of lungworm disease and for vaccination |
| 02/02/2000 | EP0975754A1 Osteoprotegerin binding proteins and receptors |
| 02/02/2000 | EP0975752A1 Human cerberus protein |
| 02/02/2000 | EP0975751A1 A tm4sf human tumor-associated antigen |
| 02/02/2000 | EP0975747A1 Polypeptide capable of reacting with antibodies of patients suffering from multiple sclerosis and uses |
| 02/02/2000 | EP0975674A1 Immunotoxins, comprising an onc protein, directed against malignant cells |
| 02/02/2000 | EP0975672A1 Antibodies for inhibiting blood coagulation and methods of use thereof |
| 02/02/2000 | EP0975668A1 MODIFIED TNF$g(a) MOLECULES, DNA ENCODING SUCH MODIFIED TNF$g(a) MOLECULES AND VACCINES COMPRISING SUCH MODIFIED TNF$g(a) MOLECULES AND DNA |
| 02/02/2000 | EP0975666A2 Compositions and methods for the treatment and diagnosis of breast cancer |
| 02/02/2000 | EP0975663A1 Helicobacter pylori antigens |
| 02/02/2000 | EP0975380A2 Membrane system for controlled tissue regeneration in cases of diseases of the peridontium |
| 02/02/2000 | EP0975368A1 Sustained drug delivery and compositions useful therefor |
| 02/02/2000 | EP0975365A1 Pharmaceutically active agents that impede the formation of amyloid by impeding the genesis or growth of dms |
| 02/02/2000 | EP0975364A1 Allergen formulation |
| 02/02/2000 | EP0975363A1 Attenuated respiratory syncytial virus |
| 02/02/2000 | EP0975362A2 Pharmaceutical or food composition for treating pathologies related to graft versus host, allergic or autoimmune reaction |
| 02/02/2000 | EP0975361A1 Methods of modulating immune coagulation |
| 02/02/2000 | EP0975360A2 Bovine respiratory and enteric coronovirus as a vaccine |
| 02/02/2000 | EP0975359A1 Potentiation of the immune response through delivery of compounds binding a cytoplasmic dipeptidase |
| 02/02/2000 | EP0975356A1 Pulsatile delivery of leptin receptor ligands |
| 02/02/2000 | EP0975355A2 Hexameric fusion proteins and uses therefor |
| 02/02/2000 | EP0975350A1 Use of an extract of alchemilli vulgaris |
| 02/02/2000 | EP0975225A1 Fibrocyte-based cellular therapy formulations |
| 02/02/2000 | EP0713529B1 Growth differentiation factor of the TGF-B family |
| 02/02/2000 | EP0584136B1 Determination of motifs of peptides on mhc molecules |
| 02/02/2000 | CN1243543A Purification and/or concentration of DNA by cross-flow filtration, separation of endotoxins from nucleic acid preparation |
| 02/01/2000 | US6020478 Human tumor-associated antigen |
| 02/01/2000 | US6020468 Antibodies directed against binding-associated epitopes |
| 02/01/2000 | US6020466 Myeloid cell leukemia associated gene mcl-1 |
| 02/01/2000 | US6020327 Control of hair growth |
| 02/01/2000 | US6020319 Nucleic acid based immunotherapy of chronic hepatitis B infection |
| 02/01/2000 | US6020309 Pharmaceuticals based on papillomaviruses |
| 02/01/2000 | US6020195 Antibodies against hepatitis G virus and their use for the diagnostic detection of HGV and as a therapeutic agent |
| 02/01/2000 | US6020189 Fibroblast growth factor homologous factors (FHFs) and methods of use |
| 02/01/2000 | US6020183 Analog of haemophilus Hin47 with reduced protease activity |
| 02/01/2000 | US6020182 Subunit respiratory syncytial virus vaccine preparation |
| 02/01/2000 | US6020179 Nucleic acids encoding human tyrosine phosphatases |
| 02/01/2000 | US6020170 Method of preparing a monoclonal antibody |
| 02/01/2000 | US6020167 Composition used as a therapeutic agent against chronic viral hepatic diseases |
| 02/01/2000 | US6020161 PIGR-1, a member of immunoglobulin gene superfamily |
| 02/01/2000 | US6020159 3-dehydroquinate synthase |
| 02/01/2000 | US6020157 Polynucleotides encoding HFGAN72X receptor |
| 02/01/2000 | US6020155 Nucleic acids encoding CR1 fusion protein, vector, transfected cell and expression |
| 02/01/2000 | US6020152 Lymphocyte-associated cell surface protein |
| 02/01/2000 | US6020149 Combining a microbially required nucleotide phosphatase, a nucleoside phosphate and the substance to be tested, and assessing the extent of degradation of the nucleoside phosphate in the presence and absence of the substance |
| 02/01/2000 | US6020144 These organisms have evolved a sophisticated ability to infect a host and evade their host's immune defenses. |
| 02/01/2000 | US6020143 The invention is concerned with the identification, isolation and cloning of genes which are associated with alzheimer's disease. |
| 02/01/2000 | US6020123 Oligonucleotide sequences for the amplification of the genome of the retroviruses of the HIV-2 and SIV type, and their uses for in vitro diagnosis of the infections due to these viruses |
| 02/01/2000 | US6020122 Hepatitis C virus second envelope (HCV-E2) glycoprotein expression system |
| 02/01/2000 | US6019987 Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof |
| 02/01/2000 | US6019985 Immunostimulation methods for providing disease protection in poultry |
| 02/01/2000 | US6019984 Bacterial preparations, method for producing same, and their use as vaccines |
| 02/01/2000 | US6019983 Gnrh peptide conjugate to e. coli fimbrial-filaments and elicits an immune response against gnrh. |
| 02/01/2000 | US6019982 Mutant enterotoxin effective as a non-toxic oral adjuvant |
| 02/01/2000 | US6019981 Modified live Edwardsiella ictaluri against enteric septicemia in channel catfish |
| 02/01/2000 | US6019980 Nucleic acid respiratory syncytial virus vaccines |
| 02/01/2000 | US6019979 Anti-viral treatment with pertussis toxin B oligomer |
| 02/01/2000 | US6019978 Replication-defective adenovirus human type 5 recombinant as a vaccine carrier |
| 02/01/2000 | US6019973 Vaccine against enterotoxin-induced illness. |
| 02/01/2000 | US6019971 Treatment of autoimmune arthritis by oral administration of collagen |
| 02/01/2000 | US6019968 Dispersible antibody compositions and methods for their preparation and use |
| 02/01/2000 | US6019967 Therapeutic/cosmetic compositions comprising CGRP antagonists for treating sensitive human skin |
| 02/01/2000 | CA2171982C Drug binding protein |
| 02/01/2000 | CA2047681C Vaccines for nontypable haemophilus influenzae |
| 02/01/2000 | CA2035039C Recombinant poxvirus and streptococcal m protein vaccine |
| 02/01/2000 | CA1340888C Vaccines and diagnostic assays for haemophilus influenzae |
| 02/01/2000 | CA1340887C Sialic acid glycosides, antigens, immunoadsorbents, and methods for thier preparation |
| 01/29/2000 | CA2279316A1 Vaccines for prevention of gram-negative bacterial infections and endotoxin-related diseases |
| 01/27/2000 | WO2000004150A1 Human presenilin-associated protein |
| 01/27/2000 | WO2000004149A2 Compositions and methods for therapy and diagnosis of prostate cancer |
| 01/27/2000 | WO2000004144A1 Snurpotine i human m3g-cap specific nucleus import receptor protein with new domain structure, the production and use thereof |
| 01/27/2000 | WO2000004137A1 Human aspartic proteases |
| 01/27/2000 | WO2000004041A2 Methods and molecules relating to cd39-like polypeptides |
| 01/27/2000 | WO2000003745A2 Polysaccharide vaccine for staphylococcal infections |
| 01/27/2000 | WO2000003744A2 Adjuvant and vaccine compositions containing monophosphoryl lipid a |
| 01/27/2000 | WO2000003732A1 Use of inactivated immunosuppressive and/or angiogenic immunogenic proteins, preparation method and pharmaceutical or vaccine uses |
| 01/27/2000 | WO2000003731A2 Vaccine to prevent and treat chlamydial infections |
| 01/27/2000 | WO2000003730A1 Urease based vaccine against helicobacter infection |
| 01/27/2000 | WO2000003728A1 Chemokines as adjuvants of immune response |
| 01/27/2000 | WO2000003724A1 Preparations for immunotherapy for cancer having bacterial somatic constituent as the active ingredient |
| 01/27/2000 | WO2000003693A1 Survivin, and peptides thereof, as an anti-cancer vaccine |
| 01/27/2000 | WO1999064604A3 Attenuated pestiviruses |
| 01/27/2000 | WO1999063050A3 Method for preparation and in vivo administration of antigen presenting cell composition |
| 01/27/2000 | WO1999059624A3 Composition for inducing a tumor-specific immune response, method for the production and utilization of said composition in the treatment of neoplasia |
| 01/27/2000 | WO1999058682A3 Compounds from moraxella catarrhalis |
| 01/27/2000 | WO1999058564B1 Frameshift mutants of beta-amyloid precursor protein and ubiquitin-b and their use |
| 01/27/2000 | WO1999057278A3 IMMUNIZATION AGAINST AND TREATMENT FOR INFECTION BY $i(H.PYLORI) |
| 01/27/2000 | WO1999039735A9 Live vaccine for human immunodeficiency virus |
| 01/27/2000 | WO1999023227A9 Hyaluronan synthase gene and uses thereof |
| 01/27/2000 | CA2337445A1 Preparations for immunotherapy for cancer having bacterial somatic constituent as the active ingredient |
| 01/27/2000 | CA2335096A1 Methods and materials relating to novel cd39-like polypeptides |
| 01/27/2000 | CA2334038A1 Compositions and methods for therapy and diagnosis of prostate cancer |
| 01/27/2000 | CA2333931A1 Polysaccharide vaccine for staphylococcal infections |